These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 31550834)

  • 1. [Advances and perspectives of antithrombotic therapy for coronary artery diseases in China].
    Li Y; Zhao R; Han YL
    Zhonghua Xin Xue Guan Bing Za Zhi; 2019 Sep; 47(9):683-688. PubMed ID: 31550834
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antithrombotic therapy for stable coronary artery disease: the difficult quest for the holy balance.
    Danchin N; Puymirat E; Schiele F
    Eur Heart J; 2016 Jan; 37(4):409-11. PubMed ID: 26508161
    [No Abstract]   [Full Text] [Related]  

  • 3. [Recent advances in antithrombotic therapy for patients with coronary artery disease undergoing percutaneous coronary intervention].
    Liu HW; Han YL
    Zhonghua Xin Xue Guan Bing Za Zhi; 2021 Feb; 49(2):108-110. PubMed ID: 33611894
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current Antithrombotic Therapy: Beyond Coronary Artery Disease.
    Mystakidi VC; Oikonomou E; Tousoulis D
    Curr Pharm Des; 2020; 26(23):2683-2685. PubMed ID: 32586236
    [No Abstract]   [Full Text] [Related]  

  • 5. Antithrombotic Therapy in Atrial Fibrillation and Coronary Artery Disease: Does Less Mean More?
    Gue YX; Gorog DA; Lip GYH
    JAMA Cardiol; 2022 Aug; 7(8):794-795. PubMed ID: 35704350
    [No Abstract]   [Full Text] [Related]  

  • 6. Advances in the Treatment of Stable Coronary Artery Disease and Peripheral Artery Disease.
    Gibler WB
    Crit Pathw Cardiol; 2018 Jun; 17(2):53-68. PubMed ID: 29768312
    [No Abstract]   [Full Text] [Related]  

  • 7. The Management of Antiplatelet and Antithrombotic Regimens in Patients With Mechanical Valves Undergoing Percutaneous Coronary Intervention: A Forgotten Cohort?
    McCarthy CP; Verma S; Bhatt DL
    JAMA Cardiol; 2017 Jul; 2(7):713-714. PubMed ID: 28445573
    [No Abstract]   [Full Text] [Related]  

  • 8. Clinical pharmacology of antithrombotic drugs in coronary artery disease.
    Fauler J
    Ther Adv Cardiovasc Dis; 2009 Dec; 3(6):465-78. PubMed ID: 19726525
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Triple vs Dual Antithrombotic Therapy in Patients with Atrial Fibrillation and Coronary Artery Disease.
    Lopes RD; Rao M; Simon DN; Thomas L; Ansell J; Fonarow GC; Gersh BJ; Go AS; Hylek EM; Kowey P; Piccini JP; Singer DE; Chang P; Peterson ED; Mahaffey KW
    Am J Med; 2016 Jun; 129(6):592-599.e1. PubMed ID: 26797080
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antithrombotic agents in coronary artery disease.
    Cairns JA; Hirsh J; Lewis HD; Resnekov L; Théroux P
    Chest; 1992 Oct; 102(4 Suppl):456S-481S. PubMed ID: 1395829
    [No Abstract]   [Full Text] [Related]  

  • 11. Managing antithrombotic therapy in patients with both atrial fibrillation and coronary heart disease.
    Thompson PL; Verheugt FW
    Clin Ther; 2014 Sep; 36(9):1176-81. PubMed ID: 25234549
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New antithrombotic agents for the treatment of coronary artery disease: overview.
    Schneider DJ
    Coron Artery Dis; 2012 Sep; 23(6):367. PubMed ID: 22850479
    [No Abstract]   [Full Text] [Related]  

  • 13. Antithrombotics in atrial fibrillation and coronary disease.
    Velagapudi P; Turagam MK; Agrawal H; Mittal M; Kocheril AG; Aggarwal K
    Expert Rev Cardiovasc Ther; 2014 Aug; 12(8):977-86. PubMed ID: 25046150
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Almanac 2013: stable coronary artery disease.
    Islam S; Timmis A
    Wien Klin Wochenschr; 2013 Dec; 125(23-24):776-83. PubMed ID: 24297269
    [No Abstract]   [Full Text] [Related]  

  • 15. Antithrombotic therapy in acute coronary syndromes.
    Sabatine MS; Jang IK
    Acta Cardiol; 1999 Feb; 54(1):3-29. PubMed ID: 10214473
    [No Abstract]   [Full Text] [Related]  

  • 16. [Oral anticoagulants in elderly patients with coronary artery disease and atrial fibrillation].
    Gallet R; Teiger E
    Ann Cardiol Angeiol (Paris); 2018 Dec; 67(6):404-410. PubMed ID: 30342831
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trials of antithrombotic therapy in percutaneous coronary intervention: what evidence do we need to optimise our practice?
    Cuisset T; Capodanno D
    EuroIntervention; 2018 May; 14(1):19-23. PubMed ID: 29786540
    [No Abstract]   [Full Text] [Related]  

  • 18. Endeavours to define optimal antithrombotic therapy after percutaneous coronary intervention.
    Kimura T
    EuroIntervention; 2017 Dec; 13(12):e1386-e1391. PubMed ID: 29208578
    [No Abstract]   [Full Text] [Related]  

  • 19. Impact of race and gender on antithrombotic therapy.
    Capodanno D; Angiolillo DJ
    Thromb Haemost; 2010 Sep; 104(3):471-84. PubMed ID: 20664898
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ABC of antithrombotic therapy: An overview of antithrombotic therapy.
    Blann AD; Landray MJ; Lip GY
    BMJ; 2002 Oct; 325(7367):762-5. PubMed ID: 12364307
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.